On this page
Every market cycle produces the same proclamation: growth investing is dead. It was declared dead after the dot-com crash in 2000. It was declared dead again during the financial crisis of 2008. And following the 2022 growth stock meltdown, when rising interest rates crushed high-multiple companies and many unprofitable growth stocks fell 70-90% from their highs, the obituaries appeared once more. The question is not whether growth stocks experience painful corrections, because they clearly do. The question is whether the underlying logic of investing in rapidly growing companies has permanently lost its potency.
The Case Against Growth: Why Skeptics Say It Is Over
The bearish case against growth investing rests on several structural arguments that deserve serious consideration.
The era of free money is over. Growth stocks benefited enormously from the near-zero interest rate environment that prevailed from 2009 to 2022. With rates now structurally higher than the previous decade, the discount rate on future earnings has increased, mechanically reducing the fair value of growth stocks relative to value stocks. If interest rates remain in the 3-5% range rather than returning to near zero, the valuation framework that supported extreme growth multiples may not return.
Concentration risk has reached dangerous levels. The dominance of a handful of mega-cap technology companies in growth indexes means that buying a growth ETF is increasingly a bet on five to seven specific companies. This concentration makes growth investing fragile: if any of these dominant companies stumbles, experiences regulatory intervention, or faces genuine competitive disruption, the impact on growth portfolios would be outsized. The history of market concentration suggests that periods of extreme dominance by a few stocks eventually end, often painfully.
Valuation headwinds persist. U.S. growth stocks approach the mid-2020s trading at valuations near historical highs. The S&P 500’s forward P/E ratio, driven largely by its growth stock components, sits well above long-term averages. Academic research on the relationship between starting valuations and subsequent returns shows a strong negative correlation: buying at high valuations has historically produced below-average returns over the following decade. Growth stocks, which carry the highest valuations, face the strongest headwind from this relationship.
The law of large numbers constrains mega-cap growth. The largest growth companies now have market capitalizations approaching or exceeding $3 trillion. Growing revenue at 15-20% from a $400 billion base requires adding $60-80 billion in new revenue annually, an amount that exceeds the total revenue of most publicly traded companies. As these companies grow larger, maintaining the growth rates that justify their premiums becomes mathematically more difficult.
The Case For Growth: Why Reports of Its Death Are Exaggerated
Innovation continues to create new growth opportunities. The artificial intelligence revolution represents the most significant technological shift since the internet, and its economic impact is still in very early stages. AI is projected to add trillions of dollars in economic value over the coming decade through productivity gains, new products, and transformed business processes. The companies enabling and benefiting from this transformation are predominantly growth stocks: semiconductor designers, cloud infrastructure providers, enterprise software companies, and emerging AI-native businesses.
Growth companies generate real earnings now. Unlike the dot-com era, when many growth darlings had no earnings and negative cash flow, today’s leading growth companies are enormously profitable. Apple, Microsoft, Alphabet, and Meta generate hundreds of billions in combined free cash flow annually. These are not speculative ventures trading on hope; they are dominant businesses with proven earnings power and strong competitive positions. Calling this type of investing dead ignores the fundamental difference between speculative growth and profitable growth.
Structural economic shifts favor growth sectors. The ongoing digitization of the global economy continues to shift revenue from traditional industries to technology-enabled businesses. Cloud computing, digital payments, e-commerce, telemedicine, and software-as-a-service are gaining share at the expense of their analog predecessors. These secular trends operate independently of interest rate cycles and will continue driving earnings growth for digital-first companies for years to come.
Higher rates do not eliminate the growth premium; they moderate it. The discount rate mechanism that hurt growth stocks in 2022 makes extreme valuations harder to justify, but it does not eliminate the case for paying premiums for companies that are genuinely growing faster than the market. A company growing earnings at 25% annually in a 4% rate environment is still far more valuable than a company growing at 5%. The math of compounding ensures that genuine growth retains its premium, even if the magnitude of that premium is lower than during the zero-rate era.
The Nuanced Reality: Growth Is Evolving, Not Dying
The most accurate assessment is that growth investing is not dying but is undergoing a qualitative shift. The type of growth stock that succeeds in a higher-rate, more discriminating market environment differs from the type that thrived during the free money era.
Profitable growth is replacing speculative growth. During 2020-2021, the market rewarded revenue growth regardless of profitability. Companies burning hundreds of millions in cash could command multi-billion-dollar valuations on the promise of future profitability. In the current environment, the market demands demonstrated profitability alongside growth. Growth companies with strong margins, positive free cash flow, and a clear path to sustained earnings growth continue to attract capital. Unprofitable growth companies that cannot demonstrate a viable business model are being repriced permanently lower.
Reasonable valuations are required. The 2020-2021 market paid 30-50x revenue for the hottest growth stories. Today, the market typically caps premium growth companies at 15-25x forward earnings, a meaningful compression from the extremes but still a premium to the market average. This valuation normalization is healthy for long-term growth investors because it reduces the probability of devastating drawdowns and improves the starting point for future returns.
Quality metrics are becoming essential. The market is increasingly distinguishing between high-quality growth (companies with competitive moats, high returns on invested capital, and sustainable advantages) and low-quality growth (companies with no differentiation, low switching costs, and growth driven by unsustainable spending). This quality discrimination mirrors the approach of legendary growth investors like Warren Buffett and Peter Lynch, who always insisted on business quality alongside growth.
What Academic Research Says
Recent academic research from Cornell University has found that the oscillation between growth and value leadership follows a cyclical pattern rather than a permanent trend. The study identified predictable swings in value-growth performance that suggest neither style permanently dominates. This is consistent with the historical record, which shows that every extended period of growth dominance has eventually been followed by a period of value leadership, and vice versa.
Research from institutional investors like BlackRock, Morgan Stanley, and PIMCO suggests that the outlook for growth stocks remains positive but more selective. The consensus view emphasizes that AI-driven productivity gains should support higher returns on equity for companies that deploy the technology effectively, while companies that fail to adapt may see their competitive positions erode. This dispersion within the growth universe means stock selection matters more than ever.
The Fama-French growth factor research provides additional perspective. While the aggregate growth factor has not earned a consistent premium historically, the subset of growth stocks that combine growth with quality characteristics (high profitability, low leverage, stable earnings) has earned positive premiums in most periods. This suggests that growth investing done well, with attention to quality and valuation, remains a viable strategy even if the market environment is less favorable to growth in aggregate.
Lessons from Previous Growth Stock Corrections
Growth investing was declared dead after the Nifty Fifty crash of the early 1970s. Yet the 1980s and 1990s produced one of the greatest growth stock bull markets in history. Growth investing was declared dead after the dot-com bust of 2000-2002. Yet the 2010s produced the most extreme growth stock outperformance ever recorded. Each time growth was pronounced dead, it was actually transitioning to a new phase that eventually rewarded patient investors.
The pattern suggests that growth stock corrections purge the excesses of the preceding boom, shake out speculative participants, and create the conditions for the next sustained advance. The companies that survive the correction are typically the ones with genuine competitive advantages and real earnings power. These survivors form the foundation of the next growth cycle, often beginning their advance at substantially lower valuations than the previous peak.
The post-2022 environment has followed this pattern. The speculative excess of the zero-rate era has been purged. Hundreds of unprofitable growth companies that went public during 2020-2021 have been decimated. The surviving growth leaders, companies like the major cloud platforms, AI infrastructure providers, and profitable software companies, are trading at more reasonable valuations and growing from even larger revenue bases. These are precisely the conditions that have historically preceded strong growth stock performance in the subsequent years.
What Growth Investors Should Do Now
Rather than debating whether growth is dead, focus on adapting your growth investing approach to the current environment.
Insist on profitability. The era of paying premium multiples for unprofitable companies is over for the foreseeable future. Focus your growth portfolio on companies with positive free cash flow, expanding margins, and clear paths to sustained earnings growth. The quality growth approach provides a framework for identifying these companies systematically.
Respect valuation. The GARP framework has rarely been more relevant. Buying growth stocks at PEG ratios below 1.5 provides a margin of safety that protects against multiple compression while still participating in earnings-driven appreciation. Let other investors chase the most expensive momentum stocks; discipline yourself to pay reasonable prices for genuine growth.
Diversify across growth themes. AI is the dominant growth narrative today, but technological innovation is broader than any single trend. Healthcare innovation, clean energy transition, financial technology, and emerging market digitization all provide growth opportunities that diversify your exposure beyond the mega-cap technology companies that dominate growth indexes.
Growth investing is not dead. It is maturing, becoming more discriminating, and demanding more of its practitioners. The investors who adapt to this new reality, embracing quality, valuation discipline, and diversification, will compound wealth through growth stocks for decades to come. Those who stubbornly cling to the speculative growth approach of the zero-rate era will continue to be disappointed. The difference is not in the strategy but in the execution.
If you want the wider context behind this, read my guide to growth vs value investing.
